April 28, 2026 AlertsCourt Denies Early Dismissal in Patent Suit Over Generic Cataract Surgery DrugBy Paul W. Kalish and Jonathan J. Madara
April 21, 2026 AlertsCourt Transfers Patent Litigation After Finding Venue Improper in New JerseyBy Paul W. Kalish and Jonathan J. Madara
April 14, 2026 AlertsChief Judge Enforces Judicial Preferences Requiring Pre-Motion LetterBy Paul W. Kalish and Jonathan J. Madara
April 09, 2026 AlertsCourt Narrows Patent Case to Direct Infringement Claims, Dismissing Willfulness and Indirect TheoriesBy Paul W. Kalish and Jonathan J. Madara
April 02, 2026 AlertsFederal Court Approves Email and Website Service on Foreign DefendantBy Paul W. Kalish and Jonathan J. Madara
March 25, 2026 AlertsPatent Lawyers Disqualified for Conflict of Interest Involving Third-Party FunderBy Paul W. Kalish and Jonathan J. Madara
March 17, 2026 AlertsDispute Over Terms of Confidentiality Order Doesn’t Stop the Discovery ClockBy Paul W. Kalish and Jonathan J. Madara
March 10, 2026 AlertsCourt Rejects Amendment to Add Indefiniteness Theories Based on Plain Language of PatentBy Paul W. Kalish and Jonathan J. Madara
February 24, 2026 AlertsCourt Interprets NJ Local Patent Rules to Allow Newly Asserted ClaimsBy Paul W. Kalish and Jonathan J. Madara
February 18, 2026 AlertsConfidential Information Cannot be ‘Un-learned’By Paul W. Kalish and Jonathan J. Madara
February 10, 2026 AlertsIn Patent Dispute, NJ Federal Court Declines to Clarify Standard for Striking Expert TheoriesBy Paul W. Kalish and Jonathan J. Madara
February 03, 2026 AlertsCourt Rejects Prospective Sealing of Markman ProceedingsBy Paul W. Kalish and Jonathan J. Madara
June 26, 2025 ArticlesHow to Navigate the Biosimilar and Biologic Markets Amid Challenging US Litigation TrendsIntellectual Asset ManagementBy Gerard P. Norton, Jonathan R. Lagarenne, Jianming Jimmy Hao, Howard S. Suh and Jonathan J. Madara
August 25, 2023 ArticlesBiosimilars and Biologics Litigation in the United StatesIAMBy Gerard P. Norton, Ph.D., Jonathan R. Lagarenne, Jianming Jimmy Hao, Ph.D., Howard S. Suh and Jonathan J. Madara
May 18, 2023 AlertsSupreme Court Unanimously Affirms Enablement Requirement in Closely Watched Amgen-Sanofi CaseBy Jonathan Madara*, Jianming Jimmy Hao, Peter F. Corless and Gerard P. Norton
March 21, 2023 ArticlesProprietary, Confidential Info, Trade Secrets, Know-How—Differences for Business SuccessThe Legal Intelligencer By Kathleen Johnson and Jonathan Madara